APO Research
Talk to an analyst

APO RESEARCH · REPORT

Veterinary Healthcare

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Veterinary Healthcare Market Outlook and Growth Opportunities 2026

2 January 2026192 pages

Choose your research edition.

Industry ResearchVeterinary Healthcare Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Veterinary Healthcare Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Veterinary Healthcare Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Veterinary Healthcare Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Veterinary Healthcare Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Veterinary Healthcare market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Veterinary Healthcare is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Veterinary Healthcare is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Veterinary Healthcare is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Veterinary Healthcare market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Veterinary Healthcare market include Zoetis, Virbac, Vetoquinol, Parnell, Ouro Fino Saude, Merck Animal Health, Meiji, Elanco Animal Health and Dechra Veterinary Products, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Veterinary Healthcare market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Veterinary Healthcare and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Veterinary Healthcare revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Veterinary Healthcare market.

Veterinary Healthcare Segment by Company

Zoetis

Virbac

Vetoquinol

Parnell

Ouro Fino Saude

Merck Animal Health

Meiji

Elanco Animal Health

Dechra Veterinary Products

Ceva

Boehringer Ingelheim

Animalcare Group

Veterinary Healthcare Segment by Type

Medicines

Vaccine

Other

Veterinary Healthcare Segment by Application

Companion Animals

Livestock Animals

Veterinary Healthcare Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Veterinary Healthcare status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Veterinary Healthcare key companies, revenue, market share, and recent developments.

3. To split the Veterinary Healthcare breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Veterinary Healthcare market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Veterinary Healthcare significant trends, drivers, influence factors in global and regions.

6. To analyze Veterinary Healthcare competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Healthcare market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary Healthcare and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Healthcare.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Veterinary Healthcare industry.

Chapter 3: Detailed analysis of Veterinary Healthcare company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Veterinary Healthcare in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Veterinary Healthcare in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Veterinary Healthcare Industry Trends Table 2. Veterinary Healthcare Industry Drivers Table 3. Veterinary Healthcare Industry Opportunities and Challenges Table 4. Veterinary Healthcare Industry Restraints Table 5. Global Veterinary Healthcare Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Veterinary Healthcare Revenue Share by Company (2021-2026) Table 7. Global Veterinary Healthcare Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Veterinary Healthcare Key Company Manufacturing Base & Headquarters Table 9. Global Veterinary Healthcare Company, Product Type & Application Table 10. Global Veterinary Healthcare Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Veterinary Healthcare by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Medicines Table 15. Significant Companies of Vaccine Table 16. Significant Companies of Other Table 17. Global Veterinary Healthcare Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Veterinary Healthcare Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Veterinary Healthcare Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Veterinary Healthcare Sales Value Share by Type (2021-2026) Table 21. Global Veterinary Healthcare Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Companion Animals Table 23. Significant Companies of Livestock Animals Table 24. Global Veterinary Healthcare Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Veterinary Healthcare Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Veterinary Healthcare Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Veterinary Healthcare Sales Value Share by Application (2021-2026) Table 28. Global Veterinary Healthcare Sales Value Share by Application (2027-2032) Table 29. Global Veterinary Healthcare Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Veterinary Healthcare Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Veterinary Healthcare Sales Value Share by Region (2021-2026) Table 32. Global Veterinary Healthcare Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Veterinary Healthcare Sales Value Share by Region (2027-2032) Table 34. Global Veterinary Healthcare Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Veterinary Healthcare Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Veterinary Healthcare Sales Value Market Share by Country (2021-2026) Table 37. Global Veterinary Healthcare Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Veterinary Healthcare Sales Value Market Share by Country (2027-2032) Table 39. Zoetis Company Information Table 40. Zoetis Business Overview Table 41. Zoetis Veterinary Healthcare Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Zoetis Veterinary Healthcare Product Portfolio Table 43. Zoetis Recent Development Table 44. Virbac Company Information Table 45. Virbac Business Overview Table 46. Virbac Veterinary Healthcare Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Virbac Veterinary Healthcare Product Portfolio Table 48. Virbac Recent Development Table 49. Vetoquinol Company Information Table 50. Vetoquinol Business Overview Table 51. Vetoquinol Veterinary Healthcare Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Vetoquinol Veterinary Healthcare Product Portfolio Table 53. Vetoquinol Recent Development Table 54. Parnell Company Information Table 55. Parnell Business Overview Table 56. Parnell Veterinary Healthcare Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Parnell Veterinary Healthcare Product Portfolio Table 58. Parnell Recent Development Table 59. Ouro Fino Saude Company Information Table 60. Ouro Fino Saude Business Overview Table 61. Ouro Fino Saude Veterinary Healthcare Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Ouro Fino Saude Veterinary Healthcare Product Portfolio Table 63. Ouro Fino Saude Recent Development Table 64. Merck Animal Health Company Information Table 65. Merck Animal Health Business Overview Table 66. Merck Animal Health Veterinary Healthcare Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Merck Animal Health Veterinary Healthcare Product Portfolio Table 68. Merck Animal Health Recent Development Table 69. Meiji Company Information Table 70. Meiji Business Overview Table 71. Meiji Veterinary Healthcare Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Meiji Veterinary Healthcare Product Portfolio Table 73. Meiji Recent Development Table 74. Elanco Animal Health Company Information Table 75. Elanco Animal Health Business Overview Table 76. Elanco Animal Health Veterinary Healthcare Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Elanco Animal Health Veterinary Healthcare Product Portfolio Table 78. Elanco Animal Health Recent Development Table 79. Dechra Veterinary Products Company Information Table 80. Dechra Veterinary Products Business Overview Table 81. Dechra Veterinary Products Veterinary Healthcare Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Dechra Veterinary Products Veterinary Healthcare Product Portfolio Table 83. Dechra Veterinary Products Recent Development Table 84. Ceva Company Information Table 85. Ceva Business Overview Table 86. Ceva Veterinary Healthcare Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Ceva Veterinary Healthcare Product Portfolio Table 88. Ceva Recent Development Table 89. Boehringer Ingelheim Company Information Table 90. Boehringer Ingelheim Business Overview Table 91. Boehringer Ingelheim Veterinary Healthcare Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Boehringer Ingelheim Veterinary Healthcare Product Portfolio Table 93. Boehringer Ingelheim Recent Development Table 94. Animalcare Group Company Information Table 95. Animalcare Group Business Overview Table 96. Animalcare Group Veterinary Healthcare Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Animalcare Group Veterinary Healthcare Product Portfolio Table 98. Animalcare Group Recent Development Table 99. Research Programs/Design for This Report Table 100. Authors List of This Report Table 101. Secondary Sources Table 102. Primary Sources List of Figures Figure 1. Veterinary Healthcare Product Image Figure 2. Global Veterinary Healthcare Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Veterinary Healthcare Market Size (2021-2032) & (US$ Million) Figure 4. Global Veterinary Healthcare Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Medicines Image Figure 8. Vaccine Image Figure 9. Other Image Figure 10. Global Veterinary Healthcare Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Veterinary Healthcare Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Veterinary Healthcare Sales Value Share by Type (2021-2032) Figure 13. Companion Animals Image Figure 14. Livestock Animals Image Figure 15. Global Veterinary Healthcare Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Veterinary Healthcare Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Veterinary Healthcare Sales Value Share by Application (2021-2032) Figure 18. Global Veterinary Healthcare Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Veterinary Healthcare Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Veterinary Healthcare Sales Value (2021-2032) & (US$ Million) Figure 21. North America Veterinary Healthcare Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Veterinary Healthcare Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Veterinary Healthcare Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Veterinary Healthcare Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Veterinary Healthcare Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Veterinary Healthcare Sales Value (2021-2032) & (US$ Million) Figure 27. South America Veterinary Healthcare Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Veterinary Healthcare Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Veterinary Healthcare Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Veterinary Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Veterinary Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Veterinary Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Veterinary Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Veterinary Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Veterinary Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Veterinary Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Veterinary Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Veterinary Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Veterinary Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Veterinary Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Veterinary Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Veterinary Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Veterinary Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Veterinary Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Veterinary Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Veterinary Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Veterinary Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Veterinary Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Veterinary Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Veterinary Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Veterinary Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Veterinary Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Veterinary Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Veterinary Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Veterinary Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Veterinary Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Veterinary Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Medicines
  • Vaccine
  • Other
Applications
  • Companion Animals
  • Livestock Animals
Companies covered
  • Zoetis
  • Virbac
  • Vetoquinol
  • Parnell
  • Ouro Fino Saude
  • Merck Animal Health
  • Meiji
  • Elanco Animal Health
  • Dechra Veterinary Products
  • Ceva
  • Boehringer Ingelheim
  • Animalcare Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Veterinary Healthcare Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Veterinary Healthcare Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Veterinary Healthcare Market Dynamics
  1. 2.1 Veterinary Healthcare Industry Trends
  2. 2.2 Veterinary Healthcare Industry Drivers
  3. 2.3 Veterinary Healthcare Industry Opportunities and Challenges
  4. 2.4 Veterinary Healthcare Industry Restraints
3 Veterinary Healthcare Market by Company
  1. 3.1 Global Veterinary Healthcare Company Revenue Ranking in 2025
  2. 3.2 Global Veterinary Healthcare Revenue by Company (2021-2026)
  3. 3.3 Global Veterinary Healthcare Company Ranking (2024-2026)
  4. 3.4 Global Veterinary Healthcare Company Manufacturing Base and Headquarters
  5. 3.5 Global Veterinary Healthcare Company Product Type and Application
  6. 3.6 Global Veterinary Healthcare Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Veterinary Healthcare Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Veterinary Healthcare Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Veterinary Healthcare Market by Type
  1. 4.1 Veterinary Healthcare Type Introduction
  2. 4.1.1 Medicines
  3. 4.1.2 Vaccine
  4. 4.1.3 Other
  5. 4.2 Global Veterinary Healthcare Sales Value by Type
  6. 4.2.1 Global Veterinary Healthcare Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Veterinary Healthcare Sales Value by Type (2021-2032)
  8. 4.2.3 Global Veterinary Healthcare Sales Value Share by Type (2021-2032)
5 Veterinary Healthcare Market by Application
  1. 5.1 Veterinary Healthcare Application Introduction
  2. 5.1.1 Companion Animals
  3. 5.1.2 Livestock Animals
  4. 5.2 Global Veterinary Healthcare Sales Value by Application
  5. 5.2.1 Global Veterinary Healthcare Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Veterinary Healthcare Sales Value by Application (2021-2032)
  7. 5.2.3 Global Veterinary Healthcare Sales Value Share by Application (2021-2032)
6 Veterinary Healthcare Regional Value Analysis
  1. 6.1 Global Veterinary Healthcare Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Veterinary Healthcare Sales Value by Region (2021-2032)
  3. 6.2.1 Global Veterinary Healthcare Sales Value by Region: 2021-2026
  4. 6.2.2 Global Veterinary Healthcare Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Veterinary Healthcare Sales Value (2021-2032)
  7. 6.3.2 North America Veterinary Healthcare Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Veterinary Healthcare Sales Value (2021-2032)
  10. 6.4.2 Europe Veterinary Healthcare Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Veterinary Healthcare Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Veterinary Healthcare Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Veterinary Healthcare Sales Value (2021-2032)
  16. 6.6.2 South America Veterinary Healthcare Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Veterinary Healthcare Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Veterinary Healthcare Sales Value Share by Country, 2025 VS 2032
7 Veterinary Healthcare Country-level Value Analysis
  1. 7.1 Global Veterinary Healthcare Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Veterinary Healthcare Sales Value by Country (2021-2032)
  3. 7.2.1 Global Veterinary Healthcare Sales Value by Country (2021-2026)
  4. 7.2.2 Global Veterinary Healthcare Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Veterinary Healthcare Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Veterinary Healthcare Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Veterinary Healthcare Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Veterinary Healthcare Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Veterinary Healthcare Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Veterinary Healthcare Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Veterinary Healthcare Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Veterinary Healthcare Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Veterinary Healthcare Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Veterinary Healthcare Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Veterinary Healthcare Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Veterinary Healthcare Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Veterinary Healthcare Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Veterinary Healthcare Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Veterinary Healthcare Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Veterinary Healthcare Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Veterinary Healthcare Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Veterinary Healthcare Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Veterinary Healthcare Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Veterinary Healthcare Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Veterinary Healthcare Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Veterinary Healthcare Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Veterinary Healthcare Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Veterinary Healthcare Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Veterinary Healthcare Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Veterinary Healthcare Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Veterinary Healthcare Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Veterinary Healthcare Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Veterinary Healthcare Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Veterinary Healthcare Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zoetis
  2. 8.1.1 Zoetis Company Information
  3. 8.1.2 Zoetis Business Overview
  4. 8.1.3 Zoetis Veterinary Healthcare Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zoetis Veterinary Healthcare Product Portfolio
  6. 8.1.5 Zoetis Recent Developments
  7. 8.2 Virbac
  8. 8.2.1 Virbac Company Information
  9. 8.2.2 Virbac Business Overview
  10. 8.2.3 Virbac Veterinary Healthcare Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Virbac Veterinary Healthcare Product Portfolio
  12. 8.2.5 Virbac Recent Developments
  13. 8.3 Vetoquinol
  14. 8.3.1 Vetoquinol Company Information
  15. 8.3.2 Vetoquinol Business Overview
  16. 8.3.3 Vetoquinol Veterinary Healthcare Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Vetoquinol Veterinary Healthcare Product Portfolio
  18. 8.3.5 Vetoquinol Recent Developments
  19. 8.4 Parnell
  20. 8.4.1 Parnell Company Information
  21. 8.4.2 Parnell Business Overview
  22. 8.4.3 Parnell Veterinary Healthcare Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Parnell Veterinary Healthcare Product Portfolio
  24. 8.4.5 Parnell Recent Developments
  25. 8.5 Ouro Fino Saude
  26. 8.5.1 Ouro Fino Saude Company Information
  27. 8.5.2 Ouro Fino Saude Business Overview
  28. 8.5.3 Ouro Fino Saude Veterinary Healthcare Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Ouro Fino Saude Veterinary Healthcare Product Portfolio
  30. 8.5.5 Ouro Fino Saude Recent Developments
  31. 8.6 Merck Animal Health
  32. 8.6.1 Merck Animal Health Company Information
  33. 8.6.2 Merck Animal Health Business Overview
  34. 8.6.3 Merck Animal Health Veterinary Healthcare Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Merck Animal Health Veterinary Healthcare Product Portfolio
  36. 8.6.5 Merck Animal Health Recent Developments
  37. 8.7 Meiji
  38. 8.7.1 Meiji Company Information
  39. 8.7.2 Meiji Business Overview
  40. 8.7.3 Meiji Veterinary Healthcare Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Meiji Veterinary Healthcare Product Portfolio
  42. 8.7.5 Meiji Recent Developments
  43. 8.8 Elanco Animal Health
  44. 8.8.1 Elanco Animal Health Company Information
  45. 8.8.2 Elanco Animal Health Business Overview
  46. 8.8.3 Elanco Animal Health Veterinary Healthcare Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Elanco Animal Health Veterinary Healthcare Product Portfolio
  48. 8.8.5 Elanco Animal Health Recent Developments
  49. 8.9 Dechra Veterinary Products
  50. 8.9.1 Dechra Veterinary Products Company Information
  51. 8.9.2 Dechra Veterinary Products Business Overview
  52. 8.9.3 Dechra Veterinary Products Veterinary Healthcare Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Dechra Veterinary Products Veterinary Healthcare Product Portfolio
  54. 8.9.5 Dechra Veterinary Products Recent Developments
  55. 8.10 Ceva
  56. 8.10.1 Ceva Company Information
  57. 8.10.2 Ceva Business Overview
  58. 8.10.3 Ceva Veterinary Healthcare Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Ceva Veterinary Healthcare Product Portfolio
  60. 8.10.5 Ceva Recent Developments
  61. 8.11 Boehringer Ingelheim
  62. 8.11.1 Boehringer Ingelheim Company Information
  63. 8.11.2 Boehringer Ingelheim Business Overview
  64. 8.11.3 Boehringer Ingelheim Veterinary Healthcare Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Boehringer Ingelheim Veterinary Healthcare Product Portfolio
  66. 8.11.5 Boehringer Ingelheim Recent Developments
  67. 8.12 Animalcare Group
  68. 8.12.1 Animalcare Group Company Information
  69. 8.12.2 Animalcare Group Business Overview
  70. 8.12.3 Animalcare Group Veterinary Healthcare Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Animalcare Group Veterinary Healthcare Product Portfolio
  72. 8.12.5 Animalcare Group Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst